| Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia DA Pollyea, BM Stevens, CL Jones, A Winters, S Pei, M Minhajuddin, ... Nature medicine 24 (12), 1859-1866, 2018 | 781 | 2018 |
| Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia S Pei, DA Pollyea, A Gustafson, BM Stevens, M Minhajuddin, R Fu, ... Cancer discovery 10 (4), 536-551, 2020 | 538 | 2020 |
| Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells BM Stevens, CL Jones, DA Pollyea, R Culp-Hill, A D’Alessandro, ... Nature cancer 1 (12), 1176-1187, 2020 | 316 | 2020 |
| PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD BM Haverkos, D Abbott, M Hamadani, P Armand, ME Flowers, ... Blood, The Journal of the American Society of Hematology 130 (2), 221-228, 2017 | 304 | 2017 |
| Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells CL Jones, BM Stevens, DA Pollyea, R Culp-Hill, JA Reisz, T Nemkov, ... Cell stem cell 27 (5), 748-764. e4, 2020 | 240 | 2020 |
| Acute illness associated with cannabis use, by route of exposure: an observational study AA Monte, SK Shelton, E Mills, J Saben, A Hopkinson, B Sonn, M Devivo, ... Annals of internal medicine 170 (8), 531-537, 2019 | 217 | 2019 |
| Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia EM Cherry, D Abbott, M Amaya, C McMahon, M Schwartz, J Rosser, ... Blood advances 5 (24), 5565-5573, 2021 | 192 | 2021 |
| A comprehensive comparative analysis of treatment modalities for sinonasal malignancies TP Robin, BL Jones, OM Gordon, A Phan, D Abbott, JD McDermott, ... Cancer 123 (16), 3040-3049, 2017 | 182 | 2017 |
| A principal components regression approach to multilocus genetic association studies K Wang, D Abbott Genetic Epidemiology: The Official Publication of the International Genetic …, 2008 | 178 | 2008 |
| Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia AC Winters, JA Gutman, E Purev, M Nakic, J Tobin, S Chase, J Kaiser, ... Blood advances 3 (20), 2911-2919, 2019 | 162 | 2019 |
| COL1A1 and COL2A1 genes and myopia susceptibility: evidence of association and suggestive linkage to the COL2A1 locus R Metlapally, YJ Li, KN Tran-Viet, D Abbott, GR Czaja, F Malecaze, ... Investigative ophthalmology & visual science 50 (9), 4080-4086, 2009 | 112 | 2009 |
| Genetic association of insulin-like growth factor-1 polymorphisms with high-grade myopia in an international family cohort R Metlapally, CS Ki, YJ Li, KN Tran-Viet, D Abbott, F Malecaze, P Calvas, ... Investigative ophthalmology & visual science 51 (9), 4476-4479, 2010 | 101 | 2010 |
| Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML … DA Pollyea, A Winters, C McMahon, M Schwartz, CT Jordan, ... Bone marrow transplantation 57 (2), 160-166, 2022 | 94 | 2022 |
| Hepatocyte growth factor and myopia: genetic association analyses in a Caucasian population T Yanovitch, YJ Li, R Metlapally, D Abbott, KNT Viet, TL Young Molecular Vision 15, 1028, 2009 | 90 | 2009 |
| An international collaborative family-based whole-genome linkage scan for high-grade myopia YJ Li, JA Guggenheim, A Bulusu, R Metlapally, D Abbott, F Malecaze, ... Investigative ophthalmology & visual science 50 (7), 3116-3127, 2009 | 89 | 2009 |
| Population-based risks for cancer in patients with ALS SB Gibson, D Abbott, JM Farnham, KK Thai, H McLean, KP Figueroa, ... Neurology 87 (3), 289-294, 2016 | 60 | 2016 |
| Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer Discov. 2020; 10: 536–551. doi: 10.1158/2159-8290 S Pei, DA Pollyea, A Gustafson, BM Stevens, M Minhajuddin, R Fu, ... CD-19-0710.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 55 | |
| Outcomes are similar after allogeneic hematopoietic stem cell transplant for newly diagnosed acute myeloid leukemia patients who received venetoclax+ azacitidine versus … AC Winters, G Bosma, D Abbott, M Minhajuddin, C Jordan, DA Pollyea, ... Transplantation and Cellular Therapy 28 (10), 694. e1-694. e9, 2022 | 51 | 2022 |
| Population-based description of familial clustering of Chiari malformation Type I D Abbott, D Brockmeyer, DW Neklason, C Teerlink, LA Cannon-Albright Journal of neurosurgery 128 (2), 460-465, 2017 | 45 | 2017 |
| Patterns of care for patients with early-stage glottic cancer undergoing definitive radiation therapy: a national cancer database analysis WA Stokes, D Abbott, A Phan, D Raben, RM Lanning, SD Karam International Journal of Radiation Oncology* Biology* Physics 98 (5), 1014-1021, 2017 | 40 | 2017 |
